All Stories

  1. Clinical practice guideline recommendation summaries for pediatric oncology health care professionals: A qualitative study

    Article • PLoS ONE, February 2023, PLOS

    Lee Dupuis

  2. Relative bioavailability of an extemporaneously prepared aprepitant oral suspension in healthy adults

    Article • Journal of Oncology Pharmacy Practice, February 2019, SAGE Publications

    Lee Dupuis

  3. Safety of clinical practice guideline-recommended antiemetic agents for the prevention of acute chemotherapy-induced nausea and vomiting in pediatric patients: a systematic review and meta-analysis

    Article • Expert Opinion on Drug Safety, January 2019, Taylor & Francis

    Lee Dupuis

  4. Identifying clinical practice guidelines for the supportive care of children with cancer: A report from the Children's Oncology Group

    Article • Pediatric Blood & Cancer, September 2018, Wiley

    Lee Dupuis

  5. Comment on: Olanzapine for chemotherapy-induced nausea: Lessons learned from child and adolescent psychiatry

    Article • Pediatric Blood & Cancer, September 2018, Wiley

    Lee Dupuis

  6. Veno-occlusive disease after high-dose busulfan–melphalan in neuroblastoma

    Article • British Journal of Pharmacology, September 2018, Springer Science + Business Media

    Lee Dupuis, Tiffany Lucas

  7. Safety and efficacy of nabilone for acute chemotherapy-induced vomiting prophylaxis in pediatric patients: A multicenter, retrospective review

    Article • Pediatric Blood & Cancer, July 2018, Wiley

    Lee Dupuis

  8. Relationship between cyclosporine area-under-the curve and acute graft versus host disease in pediatric patients undergoing hematopoietic stem cell transplant: A prospective, multicenter study

    Article • Pediatric Hematology and Oncology, May 2018, Taylor & Francis

    Lee Dupuis

  9. Validation of the Proxy Version of Symptom Screening in Pediatrics Tool in Children Receiving Cancer Treatments

    Article • Journal of Pain and Symptom Management, April 2018, Elsevier

    Lee Dupuis

  10. Response to ‘Aprepitant and fosaprepitant decrease the effectiveness of hormonal contraceptives’

    Article • British Journal of Clinical Pharmacology, January 2018, Wiley

    Lee Dupuis

  11. Acupressure bands do not improve chemotherapy-induced nausea control in pediatric patients receiving highly emetogenic chemotherapy: A single-blinded, randomized controlled trial

    Article • Cancer, December 2017, Wiley

    Lee Dupuis

  12. Aprepitant and fosaprepitant drug interactions: a systematic review

    Article • British Journal of Clinical Pharmacology, June 2017, Wiley

    Lee Dupuis

  13. Nausea and vomiting in children and adolescents receiving intrathecal methotrexate: A prospective, observational study

    Article • Pediatric Blood & Cancer, May 2017, Wiley

    Lee Dupuis

  14. Guideline for the prevention of acute chemotherapy-induced nausea and vomiting in pediatric cancer patients: A focused update

    Article • Pediatric Blood & Cancer, April 2017, Wiley

    Lee Dupuis

  15. 2016 updated MASCC/ESMO consensus recommendations: Prevention of acute chemotherapy-induced nausea and vomiting in children

    Article • Supportive Care in Cancer, August 2016, Springer Science + Business Media

    Lee Dupuis

  16. 2016 updated MASCC/ESMO consensus recommendations: Anticipatory nausea and vomiting in children and adults receiving chemotherapy

    Article • Supportive Care in Cancer, August 2016, Springer Science + Business Media

    Lee Dupuis, Professor Ian Olver

  17. The Safety of Metoclopramide in Children: A Systematic Review and Meta-Analysis

    Article • Drug Safety, March 2016, Springer Science + Business Media

    Lee Dupuis

  18. Guideline on children with challenging chemotherapy-induced nausea and vomiting

    Article • Pediatric Blood & Cancer, March 2016, Wiley

    Lee Dupuis, Bob Phillips

  19. Chemotherapy-induced vomiting in children: some progress, more questions

    Article • The Lancet Oncology, March 2016, Elsevier

    Lee Dupuis

  20. The Safety of Prochlorperazine in Children: A Systematic Review and Meta-Analysis

    Article • Drug Safety, February 2016, Springer Science + Business Media

    Lee Dupuis

  21. Chemotherapy-Induced Nausea and Vomiting Prophylaxis: Practice Within the Children's Oncology Group

    Article • Pediatric Blood & Cancer, January 2016, Wiley

    Lee Dupuis

  22. Anxiety, pain, and nausea during the treatment of standard-risk childhood acute lymphoblastic leukemia: A prospective, longitudinal study from the Children's Oncology Group

    Article • Cancer, January 2016, Wiley

    Lee Dupuis

  23. Reply to “Pharmacokinetic and Analytical Issues in Busulfan Area Under the Curve Estimation and Simulation”

    Article • Biology of Blood and Marrow Transplantation, January 2016, Elsevier

    Lee Dupuis

  24. Cardioprotection and Second Malignant Neoplasms Associated With Dexrazoxane in Children Receiving Anthracycline Chemotherapy: A Systematic Review and Meta-Analysis

    Article • JNCI Journal of the National Cancer Institute, November 2015, Oxford University Press (OUP)

    Lee Dupuis

  25. Performance of Busulfan Dosing Guidelines for Pediatric Hematopoietic Stem Cell Transplant Conditioning

    Article • Biology of Blood and Marrow Transplantation, August 2015, Elsevier

    Lee Dupuis

  26. A review of symptom screening tools in pediatric cancer patients

    Article • Current Opinion in Oncology, July 2015, Wolters Kluwer Health

    Lee Dupuis

  27. Methodological issues identified during cognitive interviews in the development of a pediatric cancer symptom screening tool

    Article • Psycho-Oncology, April 2015, Wiley

    Lee Dupuis

  28. Allergic Reactions Associated with Intravenous Versus Intramuscular Pegaspargase: A Retrospective Chart Review

    Article • Pediatric Drugs, April 2015, Springer Science + Business Media

    Lee Dupuis

  29. Guideline for the prevention of oral and oropharyngeal mucositis in children receiving treatment for cancer or undergoing haematopoietic stem cell transplantation

    Article • BMJ Supportive & Palliative Care, March 2015, BMJ

    Lee Dupuis

  30. Olanzapine for treatment and prevention of acute chemotherapy-induced vomiting in children: A retrospective, multi-center review

    Article • Pediatric Blood & Cancer, October 2014, Wiley

    Lee Dupuis

  31. The Safety of Olanzapine in Young Children: A Systematic Review and Meta-Analysis

    Article • Drug Safety, August 2014, Springer Science + Business Media

    Lee Dupuis

  32. Refinement of the Symptom Screening in Pediatrics Tool (SSPedi)

    Article • British Journal of Cancer, August 2014, Nature

    Lee Dupuis

  33. Guideline for the prevention and treatment of anticipatory nausea and vomiting due to chemotherapy in pediatric cancer patients

    Article • Pediatric Blood & Cancer, April 2014, Wiley

    Lee Dupuis

  34. Comparative effectiveness research in antineoplastic-induced nausea and vomiting control in children

    Article • Journal of Comparative Effectiveness Research, March 2014, Future Medicine

    Lee Dupuis

  35. Guideline for primary antifungal prophylaxis for pediatric patients with cancer or hematopoietic stem cell transplant recipients

    Article • Pediatric Blood & Cancer, November 2013, Wiley

    Lee Dupuis

  36. Erratum to: Initial development of the Symptom Screening in Pediatrics Tool (SSPedi)

    Article • Supportive Care in Cancer, September 2013, Springer Science + Business Media

    Lee Dupuis

  37. Initial development of the Symptom Screening in Pediatrics Tool (SSPedi)

    Article • Supportive Care in Cancer, August 2013, Springer Science + Business Media

    Lee Dupuis

  38. Methylnaltrexone for Opioid-Induced Constipation in Pediatric Oncology Patients

    Article • Pediatric Blood & Cancer, June 2013, Wiley

    Lee Dupuis

  39. Guideline for the prevention of acute nausea and vomiting due to antineoplastic medication in pediatric cancer patients

    Article • Pediatric Blood & Cancer, March 2013, Wiley

    Lee Dupuis

  40. Development and Testing of a Multidimensional iPhone Pain Assessment Application for Adolescents with Cancer

    Article • Journal of Medical Internet Research, March 2013, JMIR Publications Inc.

    Lee Dupuis

  41. Prediction of Area under the Cyclosporine Concentration Versus Time Curve in Children Undergoing Hematopoietic Stem Cell Transplantation

    Article • Biology of Blood and Marrow Transplantation, March 2013, Elsevier

    Lee Dupuis

  42. Children's Oncology Group's 2013 blueprint for research: Cancer control and supportive care

    Article • Pediatric Blood & Cancer, December 2012, Wiley

    Lee Dupuis

  43. Effect of acute graft-versus-host disease on the outcome of second allogeneic hematopoietic stem cell transplant in children

    Article • Leukemia & Lymphoma, September 2012, Taylor & Francis

    Lee Dupuis

  44. Fluoroquinolones in Children With Fever and Neutropenia

    Article • The Pediatric Infectious Disease Journal, May 2012, Wolters Kluwer Health

    Lee Dupuis

  45. A Meta-analysis of Antipseudomonal Penicillins and Cephalosporins in Pediatric Patients With Fever and Neutropenia

    Article • The Pediatric Infectious Disease Journal, April 2012, Wolters Kluwer Health

    Lee Dupuis

  46. Outpatient and oral antibiotic management of low-risk febrile neutropenia are effective in children—a systematic review of prospective trials

    Article • Supportive Care in Cancer, March 2012, Springer Science + Business Media

    Lee Dupuis

  47. A systematic review of symptom assessment scales in children with cancer

    Article • BMC Cancer, January 2012, Springer Science + Business Media

    Lee Dupuis

  48. A systematic review and meta-analysis of anti-pseudomonal penicillins and carbapenems in pediatric febrile neutropenia

    Article • Supportive Care in Cancer, December 2011, Springer Science + Business Media

    Lee Dupuis

  49. A Reliable and Safe Method of Collecting Blood Samples from Implantable Central Venous Catheters for Determination of Plasma Gentamicin Concentrations

    Article • Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy, August 2011, Wiley

    Lee Dupuis

  50. Guideline for the classification of the acute emetogenic potential of antineoplastic medication in pediatric cancer patients

    Article • Pediatric Blood & Cancer, April 2011, Wiley

    Lee Dupuis

  51. Cyclosporine Dose Intensity and Risk of Acute Graft-versus-Host Disease: Trough versus Area under the Curve

    Article • Biology of Blood and Marrow Transplantation, June 2010, Elsevier

    Lee Dupuis

  52. Practice Spotlight: Supportive Care Research in Pediatric Oncology

    Article • The Canadian Journal of Hospital Pharmacy, April 2010, Canadian Society of Hospital Pharmacists (CSHP)

    Lee Dupuis

  53. Dismal response to high-dose methylprednisolone after failure to respond to standard dose in patients with acute GVHD

    Article • British Journal of Pharmacology, March 2010, Nature

    Lee Dupuis

  54. Optimizing Emetic Control in Children Receiving Antineoplastic Therapy

    Article • Pediatric Drugs, February 2010, Springer Science + Business Media

    Lee Dupuis

  55. Once-Daily Gentamicin Dosing in Children with Febrile Neutropenia Resulting from Antineoplastic Therapy

    Article • Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy, January 2010, Wiley

    Lee Dupuis

  56. Risk Factors for Infection-Related Outcomes During Induction Therapy for Childhood Acute Lymphoblastic Leukemia

    Article • The Pediatric Infectious Disease Journal, December 2009, Wolters Kluwer Health

    Lee Dupuis

  57. Utility of peripheral blood cultures in bacteremic pediatric cancer patients with a central line

    Article • Supportive Care in Cancer, August 2009, Springer Science + Business Media

    Lee Dupuis

  58. Symptom assessment in children receiving cancer therapy: the parents’ perspective

    Article • Supportive Care in Cancer, June 2009, Springer Science + Business Media

    Lee Dupuis

  59. Daclizumab therapy for children with corticosteroid-resistant acute graft-vs.-host disease

    Article • Pediatric Transplantation, May 2009, Wiley

    Lee Dupuis

  60. Cyclosporine-Induced Pain Syndrome in a Child Undergoing Hematopoietic Stem Cell Transplant

    Article • Annals of Pharmacotherapy, March 2009, SAGE Publications

    Lee Dupuis

  61. Stability of an extemporaneous oral liquid aprepitant formulation

    Article • Supportive Care in Cancer, November 2008, Springer Science + Business Media

    Lee Dupuis

  62. Outcome and toxicity of chemotherapy for acute lymphoblastic leukemia in children with down syndrome

    Article • Pediatric Blood & Cancer, September 2008, Wiley

    Lee Dupuis

  63. Determination of initial i.v. CYA dosage to achieve target AUC values in pediatric hematopoietic stem cell transplant patients

    Article • British Journal of Pharmacology, July 2008, Nature

    Lee Dupuis

  64. Determination of Area Under the Whole Blood Concentration versus Time Curve after First Intravenous Cyclosporine Dose in Children Undergoing Hematopoietic Stem Cell Transplant: Limited Sampling Strategies

    Article • Therapeutic Drug Monitoring, July 2008, Wolters Kluwer Health

    Lee Dupuis

  65. IV Busulfan Dose Individualization in Children undergoing Hematopoietic Stem Cell Transplant: Limited Sampling Strategies

    Article • Biology of Blood and Marrow Transplantation, May 2008, Elsevier

    Lee Dupuis

  66. Sevelamer hydrochloride: A novel treatment of hyperphosphatemia associated with tumor lysis syndrome in children

    Article • Pediatric Blood & Cancer, January 2008, Wiley

    Lee Dupuis

  67. Documentation of Pediatric Drug Safety in Manufacturers??? Product Monographs

    Article • Pediatric Drugs, January 2008, Springer Science + Business Media

    Lee Dupuis

  68. Achievement of Target Cyclosporine Concentrations as a Predictor of Severe Acute Graft Versus Host Disease in Children Undergoing Hematopoietic Stem Cell Transplantation and Receiving Cyclosporine and Methotrexate Prophylaxis

    Article • Therapeutic Drug Monitoring, December 2007, Wolters Kluwer Health

    Lee Dupuis

  69. Inferior outcomes for overweight children undergoing allogeneic stem cell transplantation

    Article • British Journal of Haematology, November 2007, Wiley

    Lee Dupuis

  70. EFFICACY AND SAFETY OF CASPOFUNGIN FOR THE EMPIRIC MANAGEMENT OF FEVER IN NEUTROPENIC CHILDREN

    Article • The Pediatric Infectious Disease Journal, September 2007, Wolters Kluwer Health

    Lee Dupuis

  71. Pharmacokinetic Disposition and Clinical Outcomes in Infants and Children Receiving Intravenous Busulfan for Allogeneic Hematopoietic Stem Cell Transplantation

    Article • Biology of Blood and Marrow Transplantation, March 2007, Elsevier

    Lee Dupuis

  72. Defibrotide for the treatment of hepatic veno-occlusive disease in children

    Article • Pediatric Blood & Cancer, January 2007, Wiley

    Lee Dupuis

  73. Extent of Agreement in Gentamicin Concentration Between Serum That Is Drawn Peripherally and From Central Venous Catheters

    Article • PEDIATRICS, December 2006, American Academy of Pediatrics (AAP)

    Lee Dupuis

  74. Development and Validation of the Pediatric Nausea Assessment Tool for Use in Children Receiving Antineoplastic Agents

    Article • Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy, September 2006, Wiley

    Lee Dupuis

  75. Medication Safety: Occurrence and Impact of Unanticipated Variation in Intravenous Methotrexate Dosing

    Article • Annals of Pharmacotherapy, May 2006, SAGE Publications

    Lee Dupuis

  76. Meta-Analysis of Randomized Controlled Trials of Prophylactic Granulocyte Colony-Stimulating Factor and Granulocyte-Macrophage Colony-Stimulating Factor After Autologous and Allogeneic Stem Cell Transplantation

    Article • Journal of Clinical Oncology, January 2006, American Society of Clinical Oncology (ASCO)

    Lee Dupuis

  77. Disposition of Two Oral Formulations of Cyclosporine in Pediatric Patients Receiving Hematopoietic Stem Cell Transplants

    Article • Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy, January 2006, Wiley

    Lee Dupuis

  78. Pediatric Pharmacotherapeutic Education: Current Status and Recommendations to Fill the Growing Need

    Article • Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy, August 2005, Wiley

    Lee Dupuis

  79. A pilot study of ondansetron plus metopimazine vs. ondansetron monotherapy in children receiving highly emetogenic chemotherapy: a Bayesian randomized serial N-of-1 trials design

    Article • Supportive Care in Cancer, July 2005, Springer Science + Business Media

    Lee Dupuis

  80. Appropriate busulfan dosing

    Article • British Journal of Pharmacology, November 2004, Nature

    Lee Dupuis

  81. Tobramycin Pharmacokinetics in Children with Febrile Neutropenia Undergoing Stem Cell Transplantation: Once-Daily versus Thrice-Daily Administration

    Article • Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy, May 2004, Wiley

    Lee Dupuis

  82. Predictors of Viridans Streptococcal Shock Syndrome in Bacteremic Children With Cancer and Stem-Cell Transplant Recipients

    Article • Journal of Clinical Oncology, February 2004, American Society of Clinical Oncology (ASCO)

    Lee Dupuis

  83. Ototoxicity following pediatric hematopoietic stem cell transplantation: A prospective cohort study

    Article • Pediatric Blood & Cancer, January 2004, Wiley

    Lee Dupuis

  84. Retrospective appraisal of busulfan dose adjustment in children

    Article • British Journal of Pharmacology, April 2003, Nature

    Lee Dupuis

  85. Pharmacologic Management of Painful Oncology Procedures in Pediatrics

    Article • American Journal of Cancer, January 2003, Springer Science + Business Media

    Lee Dupuis

  86. Options for the Prevention and Management of Acute Chemotherapy-Induced Nausea and Vomiting in Children

    Article • Pediatric Drugs, January 2003, Springer Science + Business Media

    Lee Dupuis

  87. Outcomes of antiemetic prophylaxis in children undergoing bone marrow transplantation

    Article • British Journal of Pharmacology, July 2002, Nature

    Lee Dupuis

  88. Therapeutic Drug Monitoring of Lamotrigine

    Article • Annals of Pharmacotherapy, May 2002, SAGE Publications

    Lee Dupuis

  89. Therapeutic Drug Monitoring of Lamotrigine

    Article • Annals of Pharmacotherapy, May 2002, SAGE Publications

    Lee Dupuis

  90. Delayed nausea and vomiting in children receiving antineoplastics

    Article • Medical and Pediatric Oncology, January 2001, Wiley

    Lee Dupuis

  91. VINCRISTINE TOXICITY

    Article • The Lancet, July 1985, Elsevier

    Lee Dupuis

  92. Hyperpigmentation due to topical application of silver sulfadiazine cream

    Article • Journal of the American Academy of Dermatology, June 1985, Elsevier

    Lee Dupuis